# Efficacy and Safety of Omalizumab in Bullous Pemphigoid

> **NCT00472030** · PHASE4 · COMPLETED · sponsor: **University of Iowa** · enrollment: 2 (actual)

## Conditions studied

- Bullous Pemphigoid

## Interventions

- **DRUG:** Omalizumab
- **DRUG:** prednisone

## Key facts

- **NCT ID:** NCT00472030
- **Lead sponsor:** University of Iowa
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-08
- **Primary completion:** 2010-12
- **Final completion:** 2010-12
- **Target enrollment:** 2 (ACTUAL)
- **Last updated:** 2012-10-16

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00472030

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00472030, "Efficacy and Safety of Omalizumab in Bullous Pemphigoid". Retrieved via AI Analytics 2026-08-02 from https://api.ai-analytics.org/clinical/NCT00472030. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*